Literature DB >> 27965149

Involvement of Brd4 in different steps of the papillomavirus life cycle.

Thomas Iftner1, Juliane Haedicke-Jarboui2, Shwu-Yuan Wu3, Cheng-Ming Chiang4.   

Abstract

Bromodomain-containing protein 4 (Brd4) is a cellular chromatin-binding factor and transcriptional regulator that recruits sequence-specific transcription factors and chromatin modulators to control target gene transcription. Papillomaviruses (PVs) have evolved to hijack Brd4's activity in order to create a facilitating environment for the viral life cycle. Brd4, in association with the major viral regulatory protein E2, is involved in multiple steps of the PV life cycle including replication initiation, viral gene transcription, and viral genome segregation and maintenance. Phosphorylation of Brd4, regulated by casein kinase II (CK2) and protein phosphatase 2A (PP2A), is critical for viral gene transcription as well as E1- and E2-dependent origin replication. Thus, pharmacological agents regulating Brd4 phosphorylation and inhibitors blocking phospho-Brd4 functions are promising candidates for therapeutic intervention in treating human papillomavirus (HPV) infections as well as associated disease.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Brd4; E2 protein; Papillomavirus life cycle; Papillomavirus replication; Papillomavirus transcription

Mesh:

Substances:

Year:  2016        PMID: 27965149      PMCID: PMC5325811          DOI: 10.1016/j.virusres.2016.12.006

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  66 in total

1.  Binding site specificity and factor redundancy in activator protein-1-driven human papillomavirus chromatin-dependent transcription.

Authors:  Wei-Ming Wang; Shwu-Yuan Wu; A-Young Lee; Cheng-Ming Chiang
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

Review 2.  Discovery of Chemical Inhibitors of Human Bromodomains.

Authors:  Guangtao Zhang; Steven G Smith; Ming-Ming Zhou
Journal:  Chem Rev       Date:  2015-10-23       Impact factor: 60.622

Review 3.  Beta genus papillomaviruses and skin cancer.

Authors:  Peter M Howley; Herbert J Pfister
Journal:  Virology       Date:  2015-02-24       Impact factor: 3.616

4.  Variations in the association of papillomavirus E2 proteins with mitotic chromosomes.

Authors:  Jaquelline G Oliveira; Leremy A Colf; Alison A McBride
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-13       Impact factor: 11.205

5.  Structure of the papillomavirus DNA-tethering complex E2:Brd4 and a peptide that ablates HPV chromosomal association.

Authors:  Eric A Abbate; Christian Voitenleitner; Michael R Botchan
Journal:  Mol Cell       Date:  2006-12-28       Impact factor: 17.970

6.  Human papillomavirus E2 down-regulates the human telomerase reverse transcriptase promoter.

Authors:  Daeyoup Lee; Hak-Zoo Kim; Kwi Wan Jeong; Young Sam Shim; Izumi Horikawa; J Carl Barrett; Joonho Choe
Journal:  J Biol Chem       Date:  2002-05-17       Impact factor: 5.157

7.  AP-1 and ERK1 but not p38 nor JNK is required for CRPV early protein 2-dependent MMP-9 promoter activation in rabbit epithelial cells.

Authors:  Sabrina Mühlen; Andreas Behren; Thomas Iftner; Peter K Plinkert; Christian Simon
Journal:  Virus Res       Date:  2008-11-18       Impact factor: 3.303

8.  Interaction of the betapapillomavirus E2 tethering protein with mitotic chromosomes.

Authors:  Vandana Sekhar; Shawna C Reed; Alison A McBride
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

9.  The human papillomavirus type 8 E2 tethering protein targets the ribosomal DNA loci of host mitotic chromosomes.

Authors:  Atasi Poddar; Shawna C Reed; Maria G McPhillips; Jonathan E Spindler; Alison A McBride
Journal:  J Virol       Date:  2008-11-12       Impact factor: 5.103

10.  Nuclear proto-oncogene products transactivate the human papillomavirus type 16 promoter.

Authors:  W Nürnberg; M Artuc; G Vorbrueggen; F Kalkbrenner; K Moelling; B M Czarnetzki; D Schadendorf
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

View more
  15 in total

1.  Phosphorylation of the Human Papillomavirus E2 Protein at Tyrosine 138 Regulates Episomal Replication.

Authors:  Leny Jose; Elliot J Androphy; Marsha DeSmet
Journal:  J Virol       Date:  2020-07-01       Impact factor: 5.103

2.  Regulation of the human papillomavirus type 16 late promoter by transcriptional elongation.

Authors:  William K Songock; Matthew L Scott; Jason M Bodily
Journal:  Virology       Date:  2017-04-24       Impact factor: 3.616

3.  BRD4S interacts with viral E2 protein to limit human papillomavirus late transcription.

Authors:  A Yigitliler; J Renner; C Simon; M Schneider; F Stubenrauch; T Iftner
Journal:  J Virol       Date:  2021-03-17       Impact factor: 5.103

Review 4.  Control of Viral Latency by Episome Maintenance Proteins.

Authors:  Alessandra De Leo; Abram Calderon; Paul M Lieberman
Journal:  Trends Microbiol       Date:  2019-10-14       Impact factor: 17.079

5.  Phosphorylation of a Conserved Tyrosine in the Papillomavirus E2 Protein Regulates Brd4 Binding and Viral Replication.

Authors:  Marsha DeSmet; Leny Jose; Nasro Isaq; Elliot J Androphy
Journal:  J Virol       Date:  2019-05-01       Impact factor: 6.549

Review 6.  Epigenetic Regulation of Viral Biological Processes.

Authors:  Lata Balakrishnan; Barry Milavetz
Journal:  Viruses       Date:  2017-11-17       Impact factor: 5.048

7.  Dual inhibition of BRD4 and PI3K-AKT by SF2523 suppresses human renal cell carcinoma cell growth.

Authors:  Hua Zhu; Jia-Hui Mao; Yin Wang; Dong-Hua Gu; Xiao-Dong Pan; Yuxi Shan; Bing Zheng
Journal:  Oncotarget       Date:  2017-09-30

Review 8.  Regulation of HPV transcription.

Authors:  Aline Lopes Ribeiro; Amanda Schiersner Caodaglio; Laura Sichero
Journal:  Clinics (Sao Paulo)       Date:  2018-10-11       Impact factor: 2.365

9.  Activity of CK2α protein kinase is required for efficient replication of some HPV types.

Authors:  Alla Piirsoo; Marko Piirsoo; Martin Kala; Eve Sankovski; Elina Lototskaja; Viktor Levin; Mauro Salvi; Mart Ustav
Journal:  PLoS Pathog       Date:  2019-05-15       Impact factor: 6.823

10.  ARV-825-induced BRD4 protein degradation as a therapy for thyroid carcinoma.

Authors:  Ling He; Chen Chen; Guoyu Gao; Kun Xu; Zhaoqun Ma
Journal:  Aging (Albany NY)       Date:  2020-03-12       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.